PRKCD and cancer: Decreased level of both the catalytically active fragment of PKCδ in DL mice liver and significant improvement in the level of the active fragment by ellagic acid supports cancer preventive role of ellagic acid via apoptotic stimulation by a positive feedback stimulation of the activity of both PKCδ and caspase-3.